Retroviral protease inhibiting compounds
US5142056A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | May 9, 1990 |
| Grant date | Aug 25, 1992 |
| Priority date | — |
| Expiry date | May 9, 2010 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A retroviral protease inhibiting compound of the formula EQU A--X--B or a pharmaceutically acceptable salt, prodrug or ester thereof, wherein X is a linking group; A is PA0 (1) substituted amino, PA0 (2) substituted carbonyl, PA0 (3) functionalized imino, PA0 (4) functionalized alkyl, PA0 (5) functionalized acyl, PA0 (6) functionalized heterocyclic or PA0 (7) functionalized (heterocyclic)alkyl; and B is PA0 (1) substituted carbonyl independently defined as herein, PA0 (2) substituted amino independently defined as herein, PA0 (3) functionalized imino independently defined as herein, PA0 (4) functionalized alkyl independently defined as herein, PA0 (5) functionalized acyl independently defined as herein, PA0 (6) functionalized heterocyclic independently defined as herein or PA0 (7) functionalized (heterocyclic)alkyl independently defined as herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.